Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study

Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study

Background: The VEDERA (Very Early vs. Delayed Etanercept in Rheumatoid Arthritis) randomised controlled trial compared the effect of conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) therapy with biologic DMARD (bDMARD) therapy using the tumour necrosis factor inhibitor etanerc...

Full description

Bibliographic Details
Main Authors: Sven Plein, Bara Erhayiem, Graham Fent, Jacqueline Andrews, John Greenwood, Paul Baxter, Elizabeth M Hensor, Sue Pavitt, Maya H Buch
Format: Article
Language:English
Published: NIHR Journals Library 2021-03-01
Series:Efficacy and Mechanism Evaluation
Subjects:
rheumatoid arthritis
cardiovascular disease
mri
anti-tnf
methotrexate
aortic stiffness
Online Access:https://doi.org/10.3310/eme08040

Internet

https://doi.org/10.3310/eme08040

Similar Items